Lymphoedema and Nocturia/ Nocturnal Polyuria After Pelvic Lymph Node Dissection for Urogenital Cancer

Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Feb 22, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how effective a treatment called manual lymph drainage (MLD) is for patients who have mild swelling in their legs, known as lower limb lymphedema, after surgery for urogenital cancer, like prostate or bladder cancer. Lymphedema can cause uncomfortable symptoms such as swelling, heaviness, and pain in the legs. The trial aims to explore whether adding MLD to the usual care—like skin care, exercises, and using compression stockings—can help improve the situation for these patients.

To participate in this study, individuals must be between the ages of 65 and 74 and have developed lymphedema within a year after their cancer surgery. They should have non-metastatic urogenital cancer and have undergone pelvic lymph node dissection. Participants will be closely monitored and will help researchers understand if a larger study on the effectiveness of MLD is possible. This trial is currently recruiting, and anyone interested can learn more about how to get involved.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients included in the prospective observational study and developing lymphoedema within the first year after surgery
• • Before inclusion, written informed consent must be given according to ICH/GCP, and national/local regulations.
• Inclusion criteria of the prospective observational study were:
• • Non-metastatic urogenital cancer (i.e. prostate cancer or bladder cancer)
• • Pelvic lymph node dissection
• Exclusion Criteria: same as for the prospective observational study:
• • Radiological evidence of metastatic disease based on pelvic CT/MRI and bone scan
• • Clinical signs of chronic venous insufficiency